… , collectively referred to as progressive MS, has proven quite … of multiple sclerosis in general,
specifically that of progressive … differences between relapsing and progressive forms of MS, …

… progressive multiple sclerosis were pooled in a group of 282 patients with a progressive initial
course of multiple sclerosis … patients with secondary progressive multiple sclerosis (Table 3…

… efficacy of immunomodulatory treatment for progressive multiple sclerosis. The best correlates
of … with clinically well-characterized progressive multiple sclerosis, we report higher brain …

… The progressive phase of multiple sclerosis (MS) is the one … remains about the place of
primary progressive MS (PP-MS): … different MS subtypes with a progressive phase. We discuss …

… When we summarize these results it seems likely that the course of multiple sclerosis is
characterized by a first phase with relapsing and remitting signs and symptoms and a later phase …

Longitudinal imaging studies of primary progressive multiple sclerosis (PPMS) have shown
significant changes in MR measures over 1 to 2 years. Correlation with clinical change over …

… progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical
course characterized by a progressive … underlying neurodegeneration in multiple sclerosis (MS…

… Beta-interferon exposure and onset of secondary progressive multiple sclerosis.  … sustained
disability accrual termed secondary progressive multiple sclerosis. This phase is responsible …

… Treatment options for patients with secondary progressive multiple sclerosis are few.
Encouraging results in open-label studies prompted this randomised trial of mitoxantrone in such …

Background No treatment has consistently shown efficacy in slowing disability progression
in patients with secondary progressive multiple sclerosis (SPMS). We assessed the effect of …